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Purpose: Dose escalation of non-small cell lung cancer is 
typically limited by increasing risk of severe adverse events, 
including radiation pneumonitis (RP). Recent studies have 
demonstrated a relationship between a CBCT derived marker 
(CDM) and lung density changes on follow up imaging. This study 
investigates the relationship between a density-based CBCT 
image marker and symptomatic radiation pneumonitis. 
Methods and Materials: CDMs were extracted for NSCLC patients 
treated definitively (> 54 Gy) with fractionated radiotherapy 
between 2011 and 2013. The CDM was defined as the proportion 
of normal lung voxels receiving 20-60 Gy that demonstrated an 
intensity increase between the first and tenth fraction CBCT, as 
previously described. Only voxels with an intensity change 
greater than a defined noise threshold were included. All images 
were registered into a common volume using an intensity-based 
deformable image registration algorithm in the Elastix toolbox. 
All other image analysis was implemented in Matlab 2010b. RP 
was determined from prospective clinical records and reviewed 
retrospectively from the electronic patient record, as scored by 
the treating oncologists at follow up visits as per CTCAE v 4.0. 
Dosimetric parameters extracted included mean lung dose and 
volume of lung receiving 20 Gy (V20). Correlation of dosimetric 
parameters and the CDM to RP events was assessed by 
Spearman’s rank correlation coefficient and multivariate 
logistical regression.  
Results: After excluding patients without dose or CBCT objects, 
65 patients were identified and CDM extracted. In those patients, 
the prescription dose range was 54-74 Gy, mean lung dose range 
was 13-23 Gy and V20 range was 3.4 – 38%. The number of voxels 
with an intensity change greater than the noise level ranged from 
0-74.5% (mean 5.3%). Symptomatic RP (≥ Grade 2) occurred in 
26.1% of patients of these patients. Spearman's rank correlation 
demonstrated significant association between mean lung dose 
and V20 with symptomatic radiation pneumonitis (p = 0.044 and 
p = 0.036 respectively), whereas the CBCT marker was not 
correlated (p = 0.609). Univariate logistic regression of mean 
lung dose and the CBCT marker was not significantly correlated 
with symptomatic RP (p = 0.090 and p = 0.821 respectively). 
Multivariate logistic regression with mean lung dose and the 
CBCT marker was not significant (p = 0.077). 
Conclusions: One previously described density-related CDM was 
not correlated with RP in this dataset. Further research is 
required to characterize the role of imaging markers in 
predicting radiation pneumonitis. 
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Purpose: Total body irradiation (TBI) is used prior to bone 
marrow transplantation as part of the conditioning regimen in 
selected patients. A linear accelerator based technique has been 
used at our treatment centre, between 2004 and 2015. 
Compensators to account for missing tissue in the head and neck 
and lower leg regions, as well as a lung attenuator for internal 
inhomogeneity resulting from low density lung tissue are 
routinely used. Dose variation within ten percent of the 
prescribed midplane dose is considered acceptable. The purpose 
of this study was to determine whether dose variation was within 
acceptable limits for patients who underwent TBI. 
Methods and Materials: Following chart review, 129 patients 
between June 2004 and August 2015 who received TBI in six 
fractions were included in this study. Patients receiving single 
fraction treatment were excluded. MOSFET dosimetry was used 
to measure surface dose at 4 or 5 locations when patients 
received the first fraction of TBI. Dosimetry was repeated during 
the second fraction for any site with variation greater than ten 
percent, or when MOSFET position was noted to have shifted. 
Statistical analysis on patient data, diagnosis and dosimetry 
measurements was carried out using a Microsoft Excel 
spreadsheet. 
Results: Of the 129 patients who met the inclusion criteria, 50 
were diagnosed with AML, 30 with ALL and 11 with CML. The rest 
of the patients were diagnosed with lymphoma or MDS. The mean 
percent variation in dosimetry ranged between 3.5% and 8.3%. 
The highest variation was found in cheek dosimetry. A high 
percentage of dosimetry readings (85.5%) were within the 
acceptable range. The highest number of individual readings 
outside ± 10% was found at the leg. The median percentage 
variation was low (3.3% to 5.1%) depending on location.  
Conclusions: A retrospective analysis of 129 patients was carried 
out for the period 2004 to 2015. The analysis shows acceptable 
variation in dosimetry within ten percent. The top three 
locations with greatest variation were the cheek, the chest, and 
the leg respectively. We conclude that linear accelerator 
delivered TBI at our centre meets the acceptable limits of dose 
variation for 129 patients over a 10-year period. The reasons for 
variation at particular sites will be discussed. 
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Purpose: The CanMEDS framework defines the core physician 
roles on which specialist medical education in Canada is based. 
The revised CanMEDS 2015 framework introduces “Leader” as a 
new CanMEDS competency. In this study, we identified 
leadership training gaps in radiation oncology residency and 
developed a focused curriculum specific to radiation oncology to 
meet this new competency requirement. 
Methods and Materials: A questionnaire was administered to 
senior residents and recent graduates of a radiation oncology 
residency training program in Canada. Qualitative data regarding 
staff and resident leadership responsibilities, leadership training 
in residency, and any perceived gaps in residency leadership 
training were gathered. Based on identified educational needs, 
a leadership curriculum was developed and administered to 
current radiation oncology residents. 
Results: Following analysis of the qualitative questionnaire data, 
three modules were designed to address the identified gaps in 
radiation oncology residency leadership training. Specifically, 
the modules were developed to increase knowledge and 
execution of different leadership styles, develop skills in 
teamwork and negotiation, and recognize specific leadership 
qualities within each resident. 
Conclusions: In this study, we identified important leadership 
competencies for radiation oncology residents as they transition 
into fellowship and junior consultant positions. To our 
knowledge, this is the first description of a radiation oncology-
specific leadership curriculum designed to meet these needs.  
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Purpose: The use of 3D printing technology to create precise 
anatomical models is well documented. These models are used 
by surgeons to better plan upcoming operations and to save 
valuable operating room time. They are also used to educate 
other members of the health care team, such as residents, 
medical students and nurses. However, the use of these 
anatomically accurate models to educate patients in the clinical 
setting has been underutilized. At our centre, we are using 3D 
printer technology to generate accurate clinical models of 
mandibles. Our objective is to use these models to better 
